Anti-Complement C5aR1 Antibody (Avdoralimab)
Catalog No.
F1351
Anti-Complement C5aR1 Antibody (Avdoralimab)
Featured Products
Avdoralimab (IPH 5401) is a fully human IgGκ monoclonal antibody that targets complement C5a receptor 1 (C5aR1) and blocks its binding to C5a. Avdoralimab can be used in the study of complement-driven inflammatory diseases and solid tumors.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145.9 kDa
Dry ice
2226393-85-5
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
IPH5401, NN8209, NN8210
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P21730
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
Immobilized human C5AR1 VLP at 16 ug/mL can bind Anti-Complement C5aR1 Antibody (Avdoralimab)
Complement C5aR1
Please avoid freeze-thaw cycles.